Matches in SemOpenAlex for { <https://semopenalex.org/work/W2127028066> ?p ?o ?g. }
- W2127028066 endingPage "165" @default.
- W2127028066 startingPage "157" @default.
- W2127028066 abstract "Objective: The purpose of these analyses was to compare the weight and other metabolic changes between adolescents and adults during long-term (at least 24 weeks) olanzapine treatment. Method: The adult database included 86 studies with 12,425 patients with schizophrenia, schizoaffective disorder, depression, borderline personality disorder, or bipolar I disorder; the adolescent database comprised six studies with 489 patients with schizophrenia, schizoaffective disorder, borderline personality disorder, bipolar I disorder, or prodromal psychosis. Patients who had at least 24 weeks of olanzapine exposure (N=4,280 from adult database and N=179 from adolescent database) were analyzed in this study. Weight data were collected for all patients, fasting glucose and lipids data were collected in some patients. For weight gain, data in 34.5% adults (4,280/12,425) and 36.6% adolescents (179/489) were analyzed while for glucose and lipids, data in 8.4% (1,038/12,425) adults and 24.9% adolescents (122/489) were analyzed. Adult patients were treated with oral (5–20 mg/day) or depot formulations (doses equivalent to oral doses of 5–20 mg/day) of olanzapine and adolescent patients were treated with oral olanzapine (2.5–20 mg/day). The incidences of potentially clinically significant categorical changes in weight and metabolic parameters were calculated with a 95% confidence interval (CI). Nonoverlapping 95% CIs were considered as indicating a statistically significant difference. Weight, lipid, and glucose change comparisons are summarized. Results: The mean age for adolescents and adults was 15.8 and 38.8, respectively. The percentage of the male population was similar for both adults (58.5%) and adolescents (62.8%). The median duration of the follow-up period was 201 days for adolescent database and 280 days for adult database. The mean weight gain from baseline to endpoint in adolescents was 11.24 kg when compared with 4.81 kg in adults. The 95% CI for adolescents (10.1, 12.4) and adults (4.57, 5.04) are not overlapping, which indicates that the difference between adolescents and adults is statistically significant. The percentage of olanzapine-treated adolescents with ≥7% mean weight gain was 89.4% compared with 55.4% in adults (Number need to harm [NNH]=3). Mean changes from baseline to endpoint were also greater for adolescents than for adults in fasting total cholesterol (5.49 mg/dL vs. 2.06 mg/dL), LDL (5.41 mg/dL vs. 0.49 mg/dL), and triglycerides (20.49 mg/dL vs. 16.72 mg/dL), but overlapping 95% CIs were observed for all lipid parameters. Mean changes from baseline to endpoint in fasting glucose values were similar between adolescents and adults (3.13 mg/dL vs. 3.95 mg/dL). However, the incidence of treatment-emergent significant glucose changes was greater in adults. Among olanzapine-treated adults and adolescents, 8.9% and 0.9% experienced a shift from normal to high and 12.5% and 3.3% experienced a shift from normal/impaired glucose tolerance (IGT) to high fasting glucose, respectively. The incidence of IGT to high elevations in glucose was greater in adolescents, but overlapping 95% CI was observed. Conclusions: The types of metabolic changes during the long-term olanzapine treatment in adolescents were similar to those observed in adults. However, the magnitude of changes in weight and lipid parameters was greater in adolescents. Patients should receive regular monitoring of weight, fasting blood glucose, and lipid profile at the beginning of, and periodically during, treatment with olanzapine." @default.
- W2127028066 created "2016-06-24" @default.
- W2127028066 creator A5002943739 @default.
- W2127028066 creator A5042279631 @default.
- W2127028066 creator A5054140183 @default.
- W2127028066 creator A5063329929 @default.
- W2127028066 creator A5070346017 @default.
- W2127028066 creator A5086273186 @default.
- W2127028066 date "2012-04-01" @default.
- W2127028066 modified "2023-09-23" @default.
- W2127028066 title "Comparison of Long-Term (At Least 24 Weeks) Weight Gain and Metabolic Changes Between Adolescents and Adults Treated with Olanzapine" @default.
- W2127028066 cites W1787454655 @default.
- W2127028066 cites W1969345212 @default.
- W2127028066 cites W1972367648 @default.
- W2127028066 cites W1994117600 @default.
- W2127028066 cites W1996113429 @default.
- W2127028066 cites W2004122611 @default.
- W2127028066 cites W2012360860 @default.
- W2127028066 cites W2019044451 @default.
- W2127028066 cites W2019505487 @default.
- W2127028066 cites W2025218882 @default.
- W2127028066 cites W2028247915 @default.
- W2127028066 cites W2028745772 @default.
- W2127028066 cites W2030771762 @default.
- W2127028066 cites W2030859524 @default.
- W2127028066 cites W2037250403 @default.
- W2127028066 cites W2038323198 @default.
- W2127028066 cites W2039055313 @default.
- W2127028066 cites W2040013231 @default.
- W2127028066 cites W2043437956 @default.
- W2127028066 cites W2049442104 @default.
- W2127028066 cites W2062359581 @default.
- W2127028066 cites W2070735132 @default.
- W2127028066 cites W2072020486 @default.
- W2127028066 cites W2078872247 @default.
- W2127028066 cites W2080502457 @default.
- W2127028066 cites W2080648851 @default.
- W2127028066 cites W2081714994 @default.
- W2127028066 cites W2085057119 @default.
- W2127028066 cites W2085184923 @default.
- W2127028066 cites W2086560982 @default.
- W2127028066 cites W2086918005 @default.
- W2127028066 cites W2088313372 @default.
- W2127028066 cites W2094915529 @default.
- W2127028066 cites W2097116748 @default.
- W2127028066 cites W2113463828 @default.
- W2127028066 cites W2119763231 @default.
- W2127028066 cites W2122538565 @default.
- W2127028066 cites W2127549590 @default.
- W2127028066 cites W2128654468 @default.
- W2127028066 cites W2136125265 @default.
- W2127028066 cites W2137391206 @default.
- W2127028066 cites W2151811004 @default.
- W2127028066 cites W2154959584 @default.
- W2127028066 cites W2160351074 @default.
- W2127028066 cites W2170562380 @default.
- W2127028066 cites W2739873817 @default.
- W2127028066 cites W4213092833 @default.
- W2127028066 cites W4244626365 @default.
- W2127028066 cites W86064851 @default.
- W2127028066 doi "https://doi.org/10.1089/cap.2010.0020" @default.
- W2127028066 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22372514" @default.
- W2127028066 hasPublicationYear "2012" @default.
- W2127028066 type Work @default.
- W2127028066 sameAs 2127028066 @default.
- W2127028066 citedByCount "44" @default.
- W2127028066 countsByYear W21270280662012 @default.
- W2127028066 countsByYear W21270280662013 @default.
- W2127028066 countsByYear W21270280662014 @default.
- W2127028066 countsByYear W21270280662015 @default.
- W2127028066 countsByYear W21270280662016 @default.
- W2127028066 countsByYear W21270280662017 @default.
- W2127028066 countsByYear W21270280662018 @default.
- W2127028066 countsByYear W21270280662019 @default.
- W2127028066 countsByYear W21270280662020 @default.
- W2127028066 countsByYear W21270280662021 @default.
- W2127028066 countsByYear W21270280662022 @default.
- W2127028066 countsByYear W21270280662023 @default.
- W2127028066 crossrefType "journal-article" @default.
- W2127028066 hasAuthorship W2127028066A5002943739 @default.
- W2127028066 hasAuthorship W2127028066A5042279631 @default.
- W2127028066 hasAuthorship W2127028066A5054140183 @default.
- W2127028066 hasAuthorship W2127028066A5063329929 @default.
- W2127028066 hasAuthorship W2127028066A5070346017 @default.
- W2127028066 hasAuthorship W2127028066A5086273186 @default.
- W2127028066 hasConcept C118552586 @default.
- W2127028066 hasConcept C126322002 @default.
- W2127028066 hasConcept C139719470 @default.
- W2127028066 hasConcept C147583825 @default.
- W2127028066 hasConcept C15744967 @default.
- W2127028066 hasConcept C162324750 @default.
- W2127028066 hasConcept C187212893 @default.
- W2127028066 hasConcept C2776174506 @default.
- W2127028066 hasConcept C2776412080 @default.
- W2127028066 hasConcept C2776619155 @default.
- W2127028066 hasConcept C2776867660 @default.
- W2127028066 hasConcept C2778541603 @default.
- W2127028066 hasConcept C2779727114 @default.